Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect

NCT02268760 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BILN 2061 ZW single rising doses
DRUG: Placebo
DRUG: BILN 2061 ZW fixed dose
OTHER: Standardized breakfast

Sponsor

Boehringer Ingelheim